Literature DB >> 19805572

Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.

Cécile Denève1, Sylvie Bouttier, Bruno Dupuy, Frédéric Barbut, Anne Collignon, Claire Janoir.   

Abstract

Recent outbreaks of Clostridium difficile infection have been related to the emergence of the NAP1/027 epidemic strain. This strain demonstrates increased virulence and resistance to the C-8-methoxyfluoroquinolones gatifloxacin and moxifloxacin. These antibiotics have been implicated as major C. difficile infection-inducing agents. We investigated by real-time reverse transcription-PCR the impact of subinhibitory concentrations of ampicillin, clindamycin, ofloxacin, and moxifloxacin on the expression of genes encoding three colonization factors, the protease Cwp84, the high-molecular-weight S-layer protein, and the fibronectin-binding protein Fbp68. We have previously shown in six non-NAP1/027 moxifloxacin-susceptible strains that the presence of ampicillin or clindamycin induced an upregulation of these genes, whereas the presence of fluoroquinolones did not. The objective of this study was to analyze the expression of these genes under the same conditions in four NAP1/027 strains, one moxifloxacin susceptible and three moxifloxacin resistant. Two in vitro-selected moxifloxacin-resistant mutants were also analyzed. Moxifloxacin resistance was associated with the Thr82-->Ile substitution in GyrA in all but one of the moxifloxacin-resistant strains. The expression of cwp84 and slpA was strongly increased after culture with ampicillin or clindamycin in NAP1/027 strains. Interestingly, after culture with fluoroquinolones, the expression of cwp84 and slpA was only increased in four moxifloxacin-resistant strains, including the NAP1/027 strains and one of the in vitro-selected mutants. The overexpression of cwp84 was correlated with increased production of the protease Cwp84. The historical NAP1/027 moxifloxacin-susceptible strain and its mutant appear to be differently regulated by fluoroquinolones. Overall, fluoroquinolones appear to favor the expression of some colonization factor-encoding genes in resistant C. difficile strains. The fluoroquinolone resistance of the NAP1/027 epidemic strains could be considered an ecological advantage. This could also increase their colonization fitness and promote the infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805572      PMCID: PMC2786344          DOI: 10.1128/AAC.00532-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  57 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.

Authors:  Nicole J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 3.  The world of subinhibitory antibiotic concentrations.

Authors:  Julian Davies; George B Spiegelman; Grace Yim
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

4.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

5.  Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.

Authors:  Simon D Baines; Jane Freeman; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2005-04-28       Impact factor: 5.790

6.  Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues.

Authors:  Emanuela Calabi; Franco Calabi; Alan D Phillips; Neil F Fairweather
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins.

Authors:  Claire Janoir; Séverine Péchiné; Charlotte Grosdidier; Anne Collignon
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

8.  Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile.

Authors:  Lisa J Drummond; David G E Smith; Ian R Poxton
Journal:  J Med Microbiol       Date:  2003-12       Impact factor: 2.472

9.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

10.  gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.

Authors:  Denise Drudy; Lorraine Kyne; Rebecca O'Mahony; Séamus Fanning
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  14 in total

Review 1.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

2.  Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics.

Authors:  Shawn I Walsh; David S Peters; Peter A Smith; Arryn Craney; Melissa M Dix; Benjamin F Cravatt; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan.

Authors:  Chun-Hsing Liao; Wen-Chien Ko; Jang-Jih Lu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

4.  Tetracycline accelerates the temporally-regulated invasion response in specific isolates of multidrug-resistant Salmonella enterica serovar Typhimurium.

Authors:  Brian W Brunelle; Shawn M D Bearson; Bradley L Bearson
Journal:  BMC Microbiol       Date:  2013-09-11       Impact factor: 3.605

5.  The frequency of tetracycline resistance genes co-detected with respiratory pathogens: a database mining study uncovering descriptive trends throughout the United States.

Authors:  Matthew D Huff; David Weisman; John Adams; Song Li; Jessica Green; Leslie L Malone; Scott Clemmons
Journal:  BMC Infect Dis       Date:  2014-08-25       Impact factor: 3.090

6.  Chloramphenicol and tetracycline decrease motility and increase invasion and attachment gene expression in specific isolates of multidrug-resistant Salmonella enterica serovar Typhimurium.

Authors:  Brian W Brunelle; Bradley L Bearson; Shawn M D Bearson
Journal:  Front Microbiol       Date:  2015-01-30       Impact factor: 5.640

7.  Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.

Authors:  Lee W Goneau; Thomas J Hannan; Roderick A MacPhee; Drew J Schwartz; Jean M Macklaim; Gregory B Gloor; Hassan Razvi; Gregor Reid; Scott J Hultgren; Jeremy P Burton
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

Review 8.  Hype or hypervirulence: a reflection on problematic C. difficile strains.

Authors:  Wiep Klaas Smits
Journal:  Virulence       Date:  2013-09-10       Impact factor: 5.882

9.  Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.

Authors:  Julian R Garneau; Louis Valiquette; Louis-Charles Fortier
Journal:  BMC Infect Dis       Date:  2014-01-15       Impact factor: 3.090

10.  Sub-Inhibitory Concentrations of Mupirocin Strongly Inhibit Alpha-Toxin Production in High-Level Mupirocin-Resistant MRSA by Down-Regulating agr, saeRS, and sarA.

Authors:  Ye Jin; Meilan Li; Yongpeng Shang; Li Liu; Xiaofei Shen; Zhihui Lv; Zhihao Hao; Jingjing Duan; Yang Wu; Chun Chen; Jingye Pan; Fangyou Yu
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.